NKGen Biotech, Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/35327aed-085e-4e2d-931a-91affe8f103e/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-27.0M | 2024-01-01 – 2024-12-31 | evidence 0001845459-25-000004 |
| FY 2023 | $-29.7M | 2023-01-01 – 2023-12-31 | evidence 0001845459-24-000007 |
| FY 2022 | $-24.3M | 2022-01-01 – 2022-12-31 | evidence 0001845459-24-000007 |
| FY 2021 | $-2.5M | 2021-01-28 – 2021-12-31 | evidence 0001410578-22-000682 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).